APA (7th ed.) Citation

Malaguarnera, M., Pistone, G., Neri, S., Romano, M., Brogna, A., & Musumeci, S. (2004). Interleukin-2 plus ribavirin versus interferon-α-2b plus ribavirin in patients with chronic hepatitis C who did not respond to previous interferon-α-2b treatment. BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 18(6), 407. https://doi.org/10.2165/00063030-200418060-00006

Chicago Style (17th ed.) Citation

Malaguarnera, Mariano, Giovanni Pistone, Sergio Neri, Marcello Romano, Alfio Brogna, and Salvatore Musumeci. "Interleukin-2 Plus Ribavirin Versus Interferon-α-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-α-2b Treatment." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals, and Gene Therapy 18, no. 6 (2004): 407. https://doi.org/10.2165/00063030-200418060-00006.

MLA (9th ed.) Citation

Malaguarnera, Mariano, et al. "Interleukin-2 Plus Ribavirin Versus Interferon-α-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-α-2b Treatment." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals, and Gene Therapy, vol. 18, no. 6, 2004, p. 407, https://doi.org/10.2165/00063030-200418060-00006.